Marked Differences in CNS Activity among EGFR Inhibitors: Case Report and Mini-Review
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference26 articles.
1. Waqar SN, Waqar SH, Trinkaus K, et al. Brain metastases at presentation in patients with non-small cell lung cancer [e-pub ahead of print]. Am J Clin Oncol. http://dx.doi.org/10.1097/COC.0000000000000230, accessed August 12, 2016.
2. Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers;Rangachari;Lung Cancer,2015
3. First-line afatinib versus chemotherapy in patients with non-small cell lung cancer and common epidermal growth factor receptor gene mutations and brain metastases;Schuler;J Thorac Oncol,2016
4. Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer;Togashi;Cancer Chemother Pharmacol,2012
5. Erlotinib versus gefitinib for control of leptomeningeal carcinomatosis in non-small-cell lung cancer;Lee;J Thorac Oncol,2013
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Complete response in a lung adenocarcinoma with pleural metastases initially treated with gefitinib and switched to osimertinib after cerebral oligo-progression with unknown T790M mutation: a case report and review of literature;Journal of Medical Case Reports;2024-08-08
2. Tyrosine kinase inhibitors in cancers: Treatment optimization – Part I;Critical Reviews in Oncology/Hematology;2024-07
3. Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes;Cancers;2022-12-28
4. Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis;Frontiers in Oncology;2022-06-07
5. Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S;Journal of Chemotherapy;2022-04-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3